CARTOX-10 Calculator
The CARTOX‑10 Calculator screens for early neurotoxicity in patients receiving CAR‑T cell therapy.
Oriented to Year
No0Yes+1
Oriented to Month
No0Yes+1
Oriented to City
No0Yes+1
Oriented to Hospital
No0Yes+1
Oriented to President/Leader
No0Yes+1
Name 3 Objects
None01+12+2All+3
Sentence Writing
No0Yes+1
Count Backwards from 100 in 10s
No0Yes+1
Indications for Use
Used to screen for early neurotoxicity in patients receiving CAR‑T cell therapy, especially during the first 10 days post‑infusion. Identifies immune effector cell–associated neurotoxicity syndrome (ICANS), guides grading, and triggers timely intervention (eg, corticosteroids, ICU monitoring). Helps track changes in mental status, predict clinical deterioration, and standardize communication across care teams.
Insights & Cautions
Detects early cardiac toxicity risk after CAR‑T, but predictive accuracy is modest and evidence limited.
- Strengths: Quick screening for high‑risk features (eg, hypotension, arrhythmias, troponin rise) derived from CARTOX consensus.
- Cautions: Not validated for surgical or general perioperative use; no large prospective validation; may miss late or subclinical cardiotoxicity and should not replace ECG/troponin‑guided assessment or guideline‑directed evaluation (AHA/ACC 2024 perioperative guideline 1).